Agency Information Collection Activities: Proposed Collection; Request, 15475-15476 [2020-05612]

Download as PDF Federal Register / Vol. 85, No. 53 / Wednesday, March 18, 2020 / Notices FEDERAL RESERVE SYSTEM Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, if any, are available for immediate inspection at the Federal Reserve Bank indicated. The applications will also be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). Comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors, Ann E. Misback, Secretary of the Board, 20th and Constitution Avenue NW, Washington, DC 20551–0001, not later than April 16, 2020. A. Federal Reserve Bank of Atlanta (Kathryn Haney, Assistant Vice President) 1000 Peachtree Street NE, Atlanta, Georgia 30309. Comments can also be sent electronically to Applications.Comments@atl.frb.org: 1. CapStar Financial Holdings, Inc., Nashville, Tennessee; to merge with FCB Corporation, Manchester, Tennessee, and thereby indirectly acquire First National Bank of Manchester, Manchester, Tennessee, and The Bank of Waynesboro, Waynesboro, Tennessee. Board of Governors of the Federal Reserve System, March 12, 2020. Yao-Chin Chao, Assistant Secretary of the Board. [FR Doc. 2020–05534 Filed 3–17–20; 8:45 am] jbell on DSKJLSW7X2PROD with NOTICES BILLING CODE P FEDERAL RETIREMENT THRIFT INVESTMENT Board Member Meeting 77 K Street NE, 10th Floor, Washington, DC 20002 March 23, 2020, 10 a.m., Telephonic VerDate Sep<11>2014 20:22 Mar 17, 2020 Jkt 250001 Open Session 1. Approval of the Minutes of the February 24, 2020 Board Meeting 2. Monthly Reports (a) Participant Activity Report (b) Legislative Report (c) Investment Performance 3. Quarterly Report: Vendor Risk Management Update 4. OERM Annual Report 5. Enterprise Risk Management Update 6. 5 Year Lifecycle Funds Project Update 7. Lifecycle Funds Study Contact Person for More Information: Kimberly Weaver, Director, Office of External Affairs, (202) 942–1640. Dated: March 12, 2020. Megan Grumbine, General Counsel, Federal Retirement Thrift Investment Board. [FR Doc. 2020–05616 Filed 3–17–20; 8:45 am] BILLING CODE 6760–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Agency Information Collection Activities: Proposed Collection; Request Agency for Healthcare Research and Quality (AHRQ), Department of Health and Human Services (HHS). ACTION: Request for information (RFI). AGENCY: For the ‘‘Opioid Management in Older Adults’’ project, AHRQ is seeking to identify innovative approaches to managing opioid medications for chronic pain that are particularly relevant for older adults. Use of long-term opioid therapy in older adults can be especially problematic because of increased risks such as delirium, falls, and dementia. DATES: Information must be received by April 25, 2020. ADDRESSES: Written comments should be submitted by email to: Opioids_ OlderAdults@abtassoc.com. FOR FURTHER INFORMATION CONTACT: Parivash Nourjah, Parivash.nourjah@ ahrq.gov, or 301–427–1106. SUPPLEMENTARY INFORMATION: The United States is in the midst of an unprecedented opioid epidemic that is affecting people from all walks of life. Regulators and policy makers have initiated many activities to curb the epidemic, but relatively little attention has been paid to the growing toll of opioid use, opioid misuse and opioid use disorder (OUD) among older adults. SUMMARY: PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 15475 The opioid crisis in older adults is strongly related to challenges in prescription opioid management in this population. Older adults have a high prevalence of chronic pain and are especially vulnerable to suffering adverse events from opioid use, making safe prescribing more challenging even when opioids are an appropriate therapeutic choice. Identifying adverse effects due to opioid use, misuse or abuse is complicated further by factors such as co-occurring medical disorders that can mimic the effects of opioid use. There is also a risk of attributing clinical findings in older adults (e.g. personality changes, falls/balance problems, difficulty sleeping, and heart problems) to other conditions that are also common with age. If adverse events due to opioid prescriptions are identified, finding appropriate alternatives for pain management can be challenging if other pharmacologic options (such as NSAIDS) are contraindicated or mobility issues limit access to other therapeutic options. Diagnosis of substance use disorders is also more complicated in this population. Clinicians may not associate drug misuse or addiction with older adults or they may be inadequately trained in identification and treatment of opioid misuse and OUD among older adults, and hence may not monitor for the signs of opioid use disorder in this population. Successfully optimizing the prescribing and use of opioids in older adults will require addressing the issue at many points along the care continuum where older adults may need additional attention or a different approach. AHRQ wants to identify specific tools, strategies and approaches to opioid management in older adults throughout the breadth of the care delivery continuum, from avoiding opioid initiation to screening for opioid misuse and opioid use disorder, as well as approaches to opioid tapering in older adults. AHRQ is interested in all innovative approaches that address the opioid management concerns in older adults listed above, but respondents are welcome to address as many or as few as they choose and to address additional areas of interest not listed. Strategies and approaches could come from a variety of health care settings including, but not limited to, primary care and other ambulatory care clinics, emergency departments, home health care organizations, skilled nursing care settings, and inpatient care. Other sources of these strategies might include health care payers, accountable care organizations, and organizations that E:\FR\FM\18MRN1.SGM 18MRN1 15476 Federal Register / Vol. 85, No. 53 / Wednesday, March 18, 2020 / Notices provide external quality improvement support. Some of the examples of the types of innovations we are looking for might be specific tools or workflows that support providers to assess the risk/ benefit balance of opioids within a multidisciplinary approach in pain management; to optimize and monitor the opioid prescribing when appropriate, including tapering strategies; to screen and treat for opioid misuse or opioid use disorder; or to involve family or other caregivers of an older adult in conversations about opioid safety. Descriptions of strategies or approaches should include the setting where it is deployed and the type of patient population served. This RFI is for planning purposes only and should not be construed as a policy, solicitation for applications, or as an obligation on the part of the Government to provide support for any ideas in response to it. AHRQ will use the information submitted in response to this RFI at its discretion, and will not provide comments to any respondent’s submission. However, responses to the RFI may be reflected in future solicitation(s) or policies. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. No proprietary, classified, confidential or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s). The contents of all submissions will be made available to the public upon request. Submitted materials must be publicly available or able to be made public. Dated: March 12, 2020. Virginia Mackay-Smith, Associate Director, Office of the Director, AHRQ. [FR Doc. 2020–05612 Filed 3–17–20; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES jbell on DSKJLSW7X2PROD with NOTICES Agency for Healthcare Research and Quality Meeting of the National Advisory Council for Healthcare Research and Quality Agency for Healthcare Research and Quality (AHRQ), HHS. ACTION: Notice of change to public meeting. AGENCY: VerDate Sep<11>2014 18:54 Mar 17, 2020 Jkt 250001 In response to recently issued OPM guidance to agencies on reducing non-essential travel, this notice announces a change to a meeting of the National Advisory Council for Healthcare Research and Quality. SUMMARY: The meeting will be held on Thursday, March 26, 2020, from 12:30 p.m. to 3:30 p.m. DATES: The meeting will now be held virtually (via WebEx). ADDRESSES: FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Designated Management Official, at the Agency for Healthcare Research and Quality, 5600 Fishers Lane, Mail Stop 06E37A, Rockville, Maryland, 20857, (301) 427– 1456. For press-related information, please contact Bruce Seeman at (301) 427–1998 or Bruce.Seeman@ AHRQ.hhs.gov. Closed captioning will be provided during the WebEx. If another reasonable accommodation for a disability is needed, please contact the Food and Drug Administration (FDA) Office of Equal Employment Opportunity and Diversity Management on (301) 827– 4840, no later than Thursday, March 19, 2020. The agenda, roster, and minutes will be available from Ms. Heather Phelps, Committee Management Officer, Agency for Healthcare Research and Quality, 5600 Fishers Lane, Rockville, Maryland 20857. Ms. Phelps’ phone number is (301) 427–1128. SUPPLEMENTARY INFORMATION: I. Purpose In accordance with section 10(a) of the Federal Advisory Committee Act, 5 U.S.C. App., this notice announces a meeting of the National Advisory Council for Healthcare Research and Quality (the Council). The Council is authorized by Section 941 of the Public Health Service Act, 42 U.S.C. 299c. In accordance with its statutory mandate, the Council is to advise the Secretary of the Department of Health and Human Services and the Director of AHRQ on matters related to AHRQ’s conduct of its mission including providing guidance on (A) priorities for health care research, (B) the field of health care research including training needs and information dissemination on health care quality and (C) the role of the Agency in light of private sector activity and opportunities for public private partnerships. The Council is composed of members of the public, appointed by the Secretary, and Federal ex-officio members specified in the authorizing legislation. PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 II. Agenda On Thursday, March 26, 2020, the Council meeting will convene at 12:30 p.m., with the call to order by the Council Chair and approval of previous Council summary notes. The meeting is open to the public and will be available via webcast at www.webconferences.com/ahrq. The meeting will begin with an update on AHRQ’s recent accomplishments and budget. The agenda will also include a discussion about 21st Century Care and AHRQ Data and Analytics Initiatives, including Synthetic Data. The meeting will adjourn at 3:30 p.m. For information on accessing the WebEx, as well as other meeting details, including information on how to make a public comment, please go to https:// www.ahrq.gov/news/events/nac/. The final agenda will be available on the AHRQ website no later than Thursday, March 19, 2020. Dated: March 12, 2020. Virginia L. Mackay-Smith, Associate Director. [FR Doc. 2020–05563 Filed 3–17–20; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families [OMB #0970–0509] Expedited OMB Review and Public Comment: Information Collection Activity; Medical Complaint Form, Contact Investigation Form: Non-TB Illness, and Contact Investigation Form: Active/Suspect TB Office of Refugee Resettlement; Administration for Children and Families; Department of Health and Human Services. ACTION: Request for public comment. AGENCY: The Office of Refugee Resettlement (ORR), Administration for Children and Families (ACF), U.S. Department of Health and Human Services (HHS), is requesting expedited review of an information collection request from the Office of Management and Budget (OMB) and inviting public comments on the proposed revisions. The request consists of the addition of questions to the Medical Complaint Form to track instances of COVID–19. DATES: Comments due within 60 days of publication. In compliance with the requirements of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Administration for Children and SUMMARY: E:\FR\FM\18MRN1.SGM 18MRN1

Agencies

[Federal Register Volume 85, Number 53 (Wednesday, March 18, 2020)]
[Notices]
[Pages 15475-15476]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-05612]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Agency Information Collection Activities: Proposed Collection; 
Request

AGENCY: Agency for Healthcare Research and Quality (AHRQ), Department 
of Health and Human Services (HHS).

ACTION: Request for information (RFI).

-----------------------------------------------------------------------

SUMMARY: For the ``Opioid Management in Older Adults'' project, AHRQ is 
seeking to identify innovative approaches to managing opioid 
medications for chronic pain that are particularly relevant for older 
adults. Use of long-term opioid therapy in older adults can be 
especially problematic because of increased risks such as delirium, 
falls, and dementia.

DATES: Information must be received by April 25, 2020.

ADDRESSES: Written comments should be submitted by email to: 
[email protected].

FOR FURTHER INFORMATION CONTACT: Parivash Nourjah, 
[email protected], or 301-427-1106.

SUPPLEMENTARY INFORMATION: The United States is in the midst of an 
unprecedented opioid epidemic that is affecting people from all walks 
of life. Regulators and policy makers have initiated many activities to 
curb the epidemic, but relatively little attention has been paid to the 
growing toll of opioid use, opioid misuse and opioid use disorder (OUD) 
among older adults.
    The opioid crisis in older adults is strongly related to challenges 
in prescription opioid management in this population. Older adults have 
a high prevalence of chronic pain and are especially vulnerable to 
suffering adverse events from opioid use, making safe prescribing more 
challenging even when opioids are an appropriate therapeutic choice. 
Identifying adverse effects due to opioid use, misuse or abuse is 
complicated further by factors such as co-occurring medical disorders 
that can mimic the effects of opioid use. There is also a risk of 
attributing clinical findings in older adults (e.g. personality 
changes, falls/balance problems, difficulty sleeping, and heart 
problems) to other conditions that are also common with age. If adverse 
events due to opioid prescriptions are identified, finding appropriate 
alternatives for pain management can be challenging if other 
pharmacologic options (such as NSAIDS) are contraindicated or mobility 
issues limit access to other therapeutic options.
    Diagnosis of substance use disorders is also more complicated in 
this population. Clinicians may not associate drug misuse or addiction 
with older adults or they may be inadequately trained in identification 
and treatment of opioid misuse and OUD among older adults, and hence 
may not monitor for the signs of opioid use disorder in this 
population.
    Successfully optimizing the prescribing and use of opioids in older 
adults will require addressing the issue at many points along the care 
continuum where older adults may need additional attention or a 
different approach. AHRQ wants to identify specific tools, strategies 
and approaches to opioid management in older adults throughout the 
breadth of the care delivery continuum, from avoiding opioid initiation 
to screening for opioid misuse and opioid use disorder, as well as 
approaches to opioid tapering in older adults.
    AHRQ is interested in all innovative approaches that address the 
opioid management concerns in older adults listed above, but 
respondents are welcome to address as many or as few as they choose and 
to address additional areas of interest not listed.
    Strategies and approaches could come from a variety of health care 
settings including, but not limited to, primary care and other 
ambulatory care clinics, emergency departments, home health care 
organizations, skilled nursing care settings, and inpatient care. Other 
sources of these strategies might include health care payers, 
accountable care organizations, and organizations that

[[Page 15476]]

provide external quality improvement support. Some of the examples of 
the types of innovations we are looking for might be specific tools or 
workflows that support providers to assess the risk/benefit balance of 
opioids within a multidisciplinary approach in pain management; to 
optimize and monitor the opioid prescribing when appropriate, including 
tapering strategies; to screen and treat for opioid misuse or opioid 
use disorder; or to involve family or other caregivers of an older 
adult in conversations about opioid safety. Descriptions of strategies 
or approaches should include the setting where it is deployed and the 
type of patient population served.
    This RFI is for planning purposes only and should not be construed 
as a policy, solicitation for applications, or as an obligation on the 
part of the Government to provide support for any ideas in response to 
it. AHRQ will use the information submitted in response to this RFI at 
its discretion, and will not provide comments to any respondent's 
submission. However, responses to the RFI may be reflected in future 
solicitation(s) or policies. Respondents are advised that the 
Government is under no obligation to acknowledge receipt of the 
information received or provide feedback to respondents with respect to 
any information submitted. No proprietary, classified, confidential or 
sensitive information should be included in your response. The 
Government reserves the right to use any non-proprietary technical 
information in any resultant solicitation(s). The contents of all 
submissions will be made available to the public upon request. 
Submitted materials must be publicly available or able to be made 
public.

    Dated: March 12, 2020.
Virginia Mackay-Smith,
Associate Director, Office of the Director, AHRQ.
[FR Doc. 2020-05612 Filed 3-17-20; 8:45 am]
 BILLING CODE 4160-90-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.